Drug Dealers in Lab Coats
FromĀ The New York Times: For decades, America has waged an ineffective war on illicit drug dealers and drug lords. However, we have failed to...
How UCLA is Fighting a Proxy Patent Battle in India
FromĀ The Wire: Xtandi, a life-prolonging cancer drug, currently does not have a patent in India, meaning that Indian cancer patients are able to access...
When the Revolution Came for Amy Cuddy
FromĀ The New York Times Magazine: The work of Amy Cuddy, a social psychologist best known for her research and viral TED talk on "power...
The Drug Industry’s Triumph Over the DEA
In this piece forĀ The Washington Post, Scott Higham and Lenny Bernstein investigate howĀ a handful of members of Congress, allied with some of the nation's...
Scales Assessing Child and Adolescent Psychopathology Lack Cross-Cultural Validity
Researchers find few existing "psychopathology scales" are appropriate for global utilization.
On the Myth of the Chemical Imbalance
In this piece forĀ Psychology Today, Mark L. Ruffalo critiques theĀ chemical imbalance theory of mental disorder and examines why the chemical imbalance mythĀ persists today despite...
Patient Advocacy Groups Aren’t Always What They Seem
FromĀ HealthNewsReview.org: Recent studies have shown that well over half of patient advocacy groups accept money from drug, biotech, or medical device companies, and nearly...
Brain Imaging Results Biased by Lack of Representative Data
What does "normal" brain development throughout childhood look like? It may depend on your demographics.
The Secretive Family Making Billions From the Opioid Crisis
In this pieceĀ forĀ Esquire, Christopher Glazek profiles the Sacklers, the family that owns the pharmaceutical company that manufactures OxyContin. He investigates how the Sacklers' marketing...
An Anarchist Teaches Patients to Make Their Own Meds
FromĀ STAT: In response to rising drug costs, anarchist and biohacker Michael Laufer plans to teach people to manufacture their own medications.
"The de facto leader...
Billion Dollar Deals and How They Changed Your World
A newĀ BBCĀ documentary,Ā "Health," investigates the deals struck between health professionals and pharmaceutical companies. The documentary includes an interview with Dr. James Davies, co-founder of the...
Study Examines Overdiagnosis of Mental Health Disorders in Childhood
Are diagnoses of mental disorders among children and adolescents in developed countries disproportionate to disease prevalence trends?
“Evidence-Based Medicine”: Corporate Medicine’s Instrument
FromĀ Medium: The notion of "evidence-based medicine" is that a particular treatment is considered effective if research finds it safe and efficacious in the majority...
Nonprofit Organization Pushes Big Pharma’s Agenda
FromĀ HealthNewsReview.org: The Alliance for Patient Access (AfPA), a nonprofit organization that claims to advocate for patients to have access to FDA-approved treatments,Ā has consistently worked...
Researchers Confirm That Relative Age Impacts ADHD Diagnosis
The youngest children in a class are more likely to receive an ADHD diagnosis than their peers.
Psychologists Push For New Approaches to Psychosis: Part 1
Psychologists and people with experience of psychotic symptoms publish a report on new ways of understanding psychosis.
Talking About Mental Health After Mass Shootings is a Cop-Out
FromĀ The Washington Post: Blaming mass shootings on "mental illness" is a distortion of the facts and a convenient way to dodge a necessary conversationĀ on...
JAMA Article Challenges CBT as Gold Standard for Psychotherapy
A review of CBT research findings raises questions about its status as the āevidence-basedā psychotherapy of choice.
Inside a Case of Repressed Memory
FromĀ The Guardian: At age 17, Nicole Kluemper came to be one of the most controversial cases in modern psychology when she recovered memories of...
Whistleblowers at Research Institutions Fear Retaliation
FromĀ The Washington Post: A new investigative report on deterrents in reporting problems with human research found evidence of fear of retaliation among whistleblowers in...
Payment Disclosure Bill is a Good First Step, but More is Needed
FromĀ The Globe and Mail: Ontario's newly proposed physician-payment disclosure law is an important first step in the direction of improved health care and increased...
Trump Blamed Pharma’s Political Donations for High Drug Prices
FromĀ STAT: On March 20th, President Trump blamed this country's "outrageous" drug prices on campaign contributions from the pharmaceutical industry. The next day, pharmaceutical companies...
Antidepressants Increase Risk of Death, Study Finds
Antidepressants are commonly considered safe and effective treatments. However, research has questioned their efficacy, and now, their safety.
Alcohol Industry is Misleading Consumers About Cancer Risk
FromĀ MinnPost: According to an international team ofĀ researchers, the alcohol industry is misleading the public by misrepresenting and downplaying evidence linking alcohol consumption with cancer.
"For...
Dr. Vinay Prasad Takes on Big Pharma and Big Medicine
In this piece forĀ STAT, Meghana Keshavan profiles Dr. Vinay Prasad, a physician who has become an influential voice in the medical community through his...
